#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Search results: (10000)



News Fatigue in Multiple Sclerosis: What Can Teriflunomide Do?

An article by French authors published in January this year in the journal Multiple Sclerosis and Related Disorders evaluated the effect of teriflunomide on fatigue in patients with multiple sclerosis in real-world practice.
Source: Multiple Sclerosis 19. 4. 2021

News Off-label use of eye drops containing bromfenac in the treatment of cystoid macular edema in the only seeing eye of a complex patient – case report

The following case report discusses the effect of repeated use of an ophthalmic preparation containing bromfenac in a patient with recurrent cystoid macular edema (CME) in the only seeing eye with advanced glaucoma. The patient has undergone more than 15 eye surgeries or procedures, has been treated for glaucoma since 2005, and has multiple intolerances to eye drops and polymorphic problems, which she attributes to the application of the drops. The dominant personality trait is an anxious approach, which, together with the complicated findings in the only seeing eye, narrows the selection of therapeutic options.
Source: Treatment of Glaucoma 14. 6. 2024

News Experience with Proton Radiotherapy for Anal Canal Carcinoma in Real Czech Practice

Radiotherapy has the potential to achieve complete tumor regression in patients with anal carcinoma, representing an effective alternative to radical surgery. However, it is associated with significant acute and late toxicity. Proton radiotherapy has shown better dose distribution in dosimetric studies compared to conventional photon therapy. What are the experiences with this treatment modality in real practice?
Source: Proton Radiotherapy 16. 10. 2023

News Teriflunomide vs. Dimethyl Fumarate in Real Practice: We Know the Winner! Will It Surprise You?

Teriflunomide and dimethyl fumarate are disease-modifying drugs (DMDs) used in the treatment of multiple sclerosis (MS). Regarding the course, form, and severity of MS, their target groups are comparable in their characteristics. These DMDs are therefore ideal candidates for mutual comparison. Swedish authors decided to compare their effectiveness based on data from real clinical practice obtained through the Swedish National Registry.
Source: Multiple Sclerosis 31. 7. 2021

News Treatment of Motor Symptoms of Parkinson's Disease

Parkinson's disease (PD) is one of the few neurodegenerative disorders for which effective symptomatic treatment is available. Unfortunately, causal or even neuroprotective therapy with proven efficacy does not yet exist, but properly chosen symptomatic therapy can positively influence the motor manifestations of the disease and significantly improve the patient's quality of life.
Source: Parkinson's Disease 12. 5. 2021

Journal articles Cholesterol metabolism disturbances and statin therapy in elderly patients

Author of the article: P. Vyroubal Source: Geriatrie a Gerontologie | 2/2013 1. 5. 2013

News Early Intervention in the Early Phase of Psychosis

A meta-analysis of 10 randomized studies examined whether early intervention in the initial phase of psychosis in patients with schizophrenia is associated with better outcomes than usual care.
Source: Modern Treatment of Schizophrenia 27. 10. 2021

News INFOGRAPHIC: Mavacamten in the treatment of obstructive hypertrophic cardiomyopathy

Obstructive hypertrophic cardiomyopathy (HCM) is most commonly caused by disorders of cardiac muscle proteins. How does targeted treatment for this disease work? We bring a concise, graphically processed overview of the efficacy and mechanism of action of the first selective cardiac myosin inhibitor.
Source: Hypertrophic Cardiomyopathy (HCM) 17. 5. 2024

News New Antidiabetic Drugs in Cardiovascular Prevention in International Recommendations

Results from studies on new antidiabetic drugs showing cardiovascular (CV) benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i, gliflozins) and glucagon-like peptide 1 receptor agonists (GLP-1RA) have led to efforts to create new recommendations for their use in patients with type 2 diabetes mellitus (T2DM) for primary and secondary CV disease prevention. A recent review by American experts succinctly summarizes what current guidelines from American and European professional societies say on this subject.
Source: Diabetes 20. 12. 2021

News Proposal of a New Treatment Sequence Algorithm for Heart Failure with Reduced Ejection Fraction

John McMurray and Milton Packer published a proposal for a new treatment sequence algorithm for patients with heart failure with reduced ejection fraction (HFrEF) based on current findings in the 2021 issue of Circulation. This procedure consists of three steps and, according to the authors, should be initiated in patients who have achieved euvolemia through the use of diuretics.
Source: Heart Failure 21. 2. 2022

News When to Consider Gaucher Disease and How to Diagnose It Early and Correctly

Considering Gaucher disease (GD) as a cause of a patient's problems, especially in the case of splenomegaly and bleeding manifestations, is very important, regardless of age. Screening using the dry blood spot method is available and very simple.
Source: Rare Diseases in Hematology 16. 5. 2023

News Etiology and Therapy of Dry Eye Syndrome in a Nutshell

Dry eye syndrome, the most common diagnosis in outpatient ophthalmology practice, is a multifactorial disease with varying severity of symptoms. It reduces the quality of life and can also affect the patient's visual functions. Therapy is individualized according to the primary trigger of the disease and aims to restore the homeostasis of the ocular surface and tear film. Due to the rapid pace of modernization associated with numerous extrinsic factors contributing to the development of dry eye syndrome, its incidence is rising, as well as the number of topical therapeutic options.
Source: Ophthalmologic Diseases 15. 2. 2023

News What impact do the symptoms of primary biliary cholangitis have on the patient and their quality of life

Primary biliary cholangitis (PBC) is a serious chronic cholestatic autoimmune liver disease that predominantly affects middle-aged women and can lead to end-stage liver failure and the need for transplantation. Several studies published this year show a reduction in the quality of life of patients with this disease due to its accompanying symptoms.
Source: Primary Biliary Cholangitis 12. 10. 2020

News What Effect Can Be Expected from Limosilactobacillus reuteri in Mucositis and Peri-Implantitis?

A Spanish clinical study monitored the effect of administering probiotics as an adjunct therapy to non-surgical mechanical treatment of peri-implantitis. What did the study show regarding the effect on microbiome composition and overall clinical picture when a preparation containing Limosilactobacillus reuteri Prodentis was administered?
Source: Dental Care 7. 6. 2024

Journal articles Autoimmune liver diseases in children. Part II

Author of the article: P. Dědek Source: Česko-slovenská pediatrie | 1/2011 3. 1. 2011

News Targeted Treatment of Children and Adolescents with Severe AD – Case Studies

The results of therapy with dupilumab in children and adolescents with severe forms of atopic dermatitis (AD) are very good even after a short period, not only from a health perspective but also in terms of the social aspect of the disease and the quality of life of patients. This is illustrated by the following two case studies – an 8-year-old girl and a 17-year-old boy – from the Center for Biological Treatment at the Dermatovenerology Clinic of the 2nd Faculty of Medicine, Charles University, and Bulovka University Hospital.
Source: Systemic treatment of atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyposis – Type 2 inflammation 2. 3. 2023

News Can We Reach Brain Metastases of Lung Cancer with Anti-EGFR Targeted Therapy?

Information on the penetration of epidermal growth factor receptor tyrosine kinase inhibitors (anti-EGFR TKIs) through the blood-brain barrier primarily comes from preclinical testing. In clinical studies, its effectiveness in patients with brain metastases can be an indicator of its penetration. However, a truly robust analysis is lacking. Until one is available, we can preliminarily evaluate the available data.
Source: Lung Cancer 11. 1. 2021

News Treatment of Depression with Persistent Severe Insomnia − Interactive Case Study

A 39-year-old patient comes to the psychiatric office due to depressive symptoms with anxiety and insomnia. He is worried about failing at work, also concerned about psychopharmaceuticals and their side effects, and is in psychotherapeutic care.
Source: Depression and Anxiety 11. 8. 2022

News Prevalence and Incidence of Age-Related Macular Degeneration in Europe – Current Overview and Trend Analysis

A comprehensive review article by authors from Bonn, Germany, published late last year in the British Journal of Ophthalmology, provides current data and estimates of the incidence and prevalence of age-related macular degeneration in Europe. Here is a brief summary of the key findings from this latest analysis.
Source: Glaucoma 6. 2. 2020

News Pregnancy and Childbirth in a Woman with VWD − A Case Study

Pregnancy and childbirth are relatively demanding periods and situations for women with von Willebrand disease (vWD) from the perspective of hemostasis. They can be associated with an increased risk of bleeding for both the mother and the newborn. For this reason, a multidisciplinary approach to every pregnant woman is essential, involving a hematologist (ideally in a specialized center), the obstetric team, and then also a gynecologist who will care for the woman in the postpartum period. The optimal approach is to create a birth plan early, which will be carefully followed during labor and especially in the postpartum period. The following case study clearly illustrates these points.
Source: Von Willebrand Disease 26. 4. 2023

News Statin Therapy May Reduce Mortality in Patients Hospitalized with COVID-19

In connection with the COVID-19 pandemic, intensive research is ongoing to understand the impact of patients' chronic medication on the prognosis of the disease. A recently published Spanish study evaluated the effect of pre-existing statin therapy on the clinical outcomes of patients hospitalized with SARS-CoV-2 infection.
Source: Cardiovascular Risks 23. 3. 2021

News Bimekizumab in 3rd Line Biological Treatment After Risankizumab Failure – Case Study

The possibilities of biological therapy for severe forms of psoriasis are very broad today. Achieving remission or reducing disease activity by 90-100% from the baseline state (PASI 90-100) is highly probable, especially when using biological drugs from the IL-17 or IL-23 inhibitor groups. However, individually, patients may exhibit primary or secondary resistance even when using these preparations, necessitating a change in biological treatment. The following case study presents the case of a young man who achieved complete disease remission with bimekizumab after the previous failure of ixekizumab and risankizumab.
Source: Psoriasis 22. 3. 2024

News Bilastine as a reliable helper in the treatment of allergic rhinoconjunctivitis and urticaria even in younger children

Until recently, bilastine was indicated for the treatment of allergic rhinoconjunctivitis and urticaria only in patients over 12 years of age. However, current findings from valid studies demonstrate the safety and efficacy of its use even in younger individuals.
Source: Allergic Reactions 21. 7. 2021

News Overview of Regimen Measures for House Dust Mite Allergy

House dust mite allergy is one of the significant causes of respiratory allergies in both children and adult patients. In addition to pharmacological treatment, the cornerstone of therapy also includes non-pharmacological approaches, whether through regimen measures or with the help of products designed to eliminate mites.
Source: Dust Mite Allergy 31. 1. 2023

News Ozanimod Expands Treatment Options for Ulcerative Colitis in Adult Patients

As a review article published last year in the journal Drugs suggests, ozanimod is an effective and well-tolerated medication for adult patients with moderate to severe ulcerative colitis (UC), both in the initial phase of treatment and in the maintenance phase after achieving remission.
Source: Modulation of S1P in the Treatment of Autoimmune Diseases 9. 5. 2023

1 44 45 46 47 48 400
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#